www.nvi-vaccins.nl
woensdag, 08 september 2010

U bevindt zich hier: news
Actueel

AmpVacs a broadly protective synthetic influenza A vaccine

Sanquin Blood Supply Foundation, the Netherlands Cancer Institute, and the Netherlands Vaccine Institute announce today the launch of their joint AmpVacs project aiming at the development of a broadly protective synthetic influenza A vaccine component that in combination with classical antibody-stimulating vaccines will induce protection against future influenza A threats.


Privacy beleid | Sitemap

© 2006-2010 The Netherlands Vaccine Institute. All rights reserved.

 

Last update: Monday july 5, 2010